Amedisys Inc to Discuss the Strategic Rationale of the Contessa Health Acquisition - M&A Call Transcript
Greetings, and welcome to the Amedisys' investor call to discuss the signing of the Contessa acquisition. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Nick Muscato. Thank you, Nick. You may begin.
Thank you, operator, and welcome to the Amedisys investor conference call to discuss our signing of the definitive agreement to acquire Contessa Health. A copy of our press release, supplemental slides and related Form 8-K filing with the SEC are available on the Investor Relations page of our website.
Speaking on today's call from Amedisys will be Paul Kusserow, Chairman and Chief Executive Officer; and from Contessa, Founder and Chief Executive Officer, Travis Messina. Also joining us is Chris Gerard, President and Chief Operating Officer; Scott Ginn, Executive Vice President and Chief Financial Officer; and Dave Kemmerly, Chief Legal and Government Affairs Officer.
Before we get started with our call, I would like to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |